HC Wainwright issued their Q1 2025 EPS estimates for shares of Zevra Therapeutics in a note issued to investors on Thursday, ...

Investment analysts at HC Wainwright boosted their FY2027 EPS estimates for shares of Oncolytics Biotech in a research report ...

H.C. Wainwright lowered the firm’s price target on Vigil Neuroscience (VIGL) to $14 from $17 and keeps a Buy rating on the shares ahead of ...

H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on IN8bio (INAB) to $6 from $8 and keeps a Buy rating on the ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

Quantum computing continues to advance rapidly, which has been helping businesses get new opportunities related to security, ...

Discover how Bit Digital's Q4 2024 results showcase a 141% revenue increase, a strategic shift to HPC with WhiteFiber, and a strong pipeline for ...

Vertical Aerospace • EVTL-NYSE Buy • $3.39 on March 12 by Canaccord Genuity We are maintaining our Buy rating on shares of ...

We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at ...

U.S. stocks were higher, with the Dow Jones index gaining around 1% on Friday. Shares of Semtech Corporation SMTC rose ...

We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at ...

Please go ahead. Good afternoon and thank you for joining us today. Earlier this afternoon, REGENXBIO released financial and operating results for the fourth-quarter and year ending December 31, 2024.